294 related articles for article (PubMed ID: 27881823)
1. Nanobodies that block gating of the P2X7 ion channel ameliorate inflammation.
Danquah W; Meyer-Schwesinger C; Rissiek B; Pinto C; Serracant-Prat A; Amadi M; Iacenda D; Knop JH; Hammel A; Bergmann P; Schwarz N; Assunção J; Rotthier W; Haag F; Tolosa E; Bannas P; Boué-Grabot E; Magnus T; Laeremans T; Stortelers C; Koch-Nolte F
Sci Transl Med; 2016 Nov; 8(366):366ra162. PubMed ID: 27881823
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567.
Bhattacharya A; Wang Q; Ao H; Shoblock JR; Lord B; Aluisio L; Fraser I; Nepomuceno D; Neff RA; Welty N; Lovenberg TW; Bonaventure P; Wickenden AD; Letavic MA
Br J Pharmacol; 2013 Oct; 170(3):624-40. PubMed ID: 23889535
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychopharmacology of JNJ-55308942: evaluation of a clinical candidate targeting P2X7 ion channels in animal models of neuroinflammation and anhedonia.
Bhattacharya A; Lord B; Grigoleit JS; He Y; Fraser I; Campbell SN; Taylor N; Aluisio L; O'Connor JC; Papp M; Chrovian C; Carruthers N; Lovenberg TW; Letavic MA
Neuropsychopharmacology; 2018 Dec; 43(13):2586-2596. PubMed ID: 30026598
[TBL] [Abstract][Full Text] [Related]
4. Inflammasome activation in bovine monocytes by extracellular ATP does not require the purinergic receptor P2X7.
Hussen J; Düvel A; Koy M; Schuberth HJ
Dev Comp Immunol; 2012 Oct; 38(2):312-20. PubMed ID: 22728096
[TBL] [Abstract][Full Text] [Related]
5. Development of Antibody and Nanobody Tools for P2X7.
Stähler T; Danquah W; Demeules M; Gondé H; Hardet R; Haag F; Adriouch S; Koch-Nolte F; Menzel S
Methods Mol Biol; 2022; 2510():99-127. PubMed ID: 35776322
[TBL] [Abstract][Full Text] [Related]
6. Involvement of purinergic receptors and NOD-like receptor-family protein 3-inflammasome pathway in the adenosine triphosphate-induced cytokine release from macrophages.
Gicquel T; Victoni T; Fautrel A; Robert S; Gleonnec F; Guezingar M; Couillin I; Catros V; Boichot E; Lagente V
Clin Exp Pharmacol Physiol; 2014 Apr; 41(4):279-86. PubMed ID: 24472059
[TBL] [Abstract][Full Text] [Related]
7. A novel radioligand for the ATP-gated ion channel P2X7: [3H] JNJ-54232334.
Lord B; Ameriks MK; Wang Q; Fourgeaud L; Vliegen M; Verluyten W; Haspeslagh P; Carruthers NI; Lovenberg TW; Bonaventure P; Letavic MA; Bhattacharya A
Eur J Pharmacol; 2015 Oct; 765():551-9. PubMed ID: 26386289
[TBL] [Abstract][Full Text] [Related]
8. Mechanical stress-induced interleukin-1beta expression through adenosine triphosphate/P2X7 receptor activation in human periodontal ligament cells.
Kanjanamekanant K; Luckprom P; Pavasant P
J Periodontal Res; 2013 Apr; 48(2):169-76. PubMed ID: 22881405
[TBL] [Abstract][Full Text] [Related]
9. N-Alkyl-Substituted Isatins Enhance P2X7 Receptor-Induced Interleukin-1β Release from Murine Macrophages.
Sluyter R; Vine KL
Mediators Inflamm; 2016; 2016():2097219. PubMed ID: 27524862
[TBL] [Abstract][Full Text] [Related]
10. Blocking P2X7 by intracerebroventricular injection of P2X7-specific nanobodies reduces stroke lesions.
Wilmes M; Pinto Espinoza C; Ludewig P; Stabernack J; Liesz A; Nicke A; Gelderblom M; Gerloff C; Falzoni S; Tolosa E; Di Virgilio F; Rissiek B; Plesnilla N; Koch-Nolte F; Magnus T
J Neuroinflammation; 2022 Oct; 19(1):256. PubMed ID: 36224611
[TBL] [Abstract][Full Text] [Related]
11. The evolution of P2X7 antagonists with a focus on CNS indications.
Rech JC; Bhattacharya A; Letavic MA; Savall BM
Bioorg Med Chem Lett; 2016 Aug; 26(16):3838-45. PubMed ID: 27426304
[TBL] [Abstract][Full Text] [Related]
12. P2X
Yin J; Wang Y; Hu H; Li X; Xue M; Cheng W; Wang Y; Li X; Yang N; Shi Y; Yan S
J Cell Mol Med; 2017 Nov; 21(11):2695-2710. PubMed ID: 28470940
[TBL] [Abstract][Full Text] [Related]
13. 8-Hydroxy-2-(1H-1,2,3-triazol-1-yl)-1,4-naphtoquinone derivatives inhibited P2X7 Receptor-Induced dye uptake into murine Macrophages.
Pacheco PAF; Galvão RMS; Faria AFM; Von Ranke NL; Rangel MS; Ribeiro TM; Bello ML; Rodrigues CR; Ferreira VF; da Rocha DR; Faria RX
Bioorg Med Chem; 2019 Apr; 27(8):1449-1455. PubMed ID: 30528164
[TBL] [Abstract][Full Text] [Related]
14. P2X7 receptor-stimulation causes fever via PGE2 and IL-1β release.
Barberà-Cremades M; Baroja-Mazo A; Gomez AI; Machado F; Di Virgilio F; Pelegrín P
FASEB J; 2012 Jul; 26(7):2951-62. PubMed ID: 22490780
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology of a novel central nervous system-penetrant P2X7 antagonist JNJ-42253432.
Lord B; Aluisio L; Shoblock JR; Neff RA; Varlinskaya EI; Ceusters M; Lovenberg TW; Carruthers N; Bonaventure P; Letavic MA; Deak T; Drinkenburg W; Bhattacharya A
J Pharmacol Exp Ther; 2014 Dec; 351(3):628-41. PubMed ID: 25271258
[TBL] [Abstract][Full Text] [Related]
16. Feasibility study of B16 melanoma therapy using oxidized ATP to target purinergic receptor P2X7.
Hattori F; Ohshima Y; Seki S; Tsukimoto M; Sato M; Takenouchi T; Suzuki A; Takai E; Kitani H; Harada H; Kojima S
Eur J Pharmacol; 2012 Nov; 695(1-3):20-6. PubMed ID: 22981895
[TBL] [Abstract][Full Text] [Related]
17. 1,4-Naphthoquinones potently inhibiting P2X7 receptor activity.
Faria RX; Oliveira FH; Salles JP; Oliveira AS; von Ranke NL; Bello ML; Rodrigues CR; Castro HC; Louvis AR; Martins DL; Ferreira VF
Eur J Med Chem; 2018 Jan; 143():1361-1372. PubMed ID: 29133043
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone II A sulfonate, but not tanshinone II A, acts as potent negative allosteric modulator of the human purinergic receptor P2X7.
Kaiser M; Sobottka H; Fischer W; Schaefer M; Nörenberg W
J Pharmacol Exp Ther; 2014 Sep; 350(3):531-42. PubMed ID: 24970925
[TBL] [Abstract][Full Text] [Related]
19. A key role for redox signaling in rapid P2X7 receptor-induced IL-1 beta processing in human monocytes.
Hewinson J; Moore SF; Glover C; Watts AG; MacKenzie AB
J Immunol; 2008 Jun; 180(12):8410-20. PubMed ID: 18523309
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic systemic P2X7 receptor blockade prevents experimental colitis.
Marques CC; Castelo-Branco MT; Pacheco RG; Buongusto F; do Rosário A; Schanaider A; Coutinho-Silva R; de Souza HS
Biochim Biophys Acta; 2014 Jan; 1842(1):65-78. PubMed ID: 24184714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]